X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (420) 420
Publication (80) 80
Patent (28) 28
Book Chapter (8) 8
Book Review (3) 3
Book / eBook (2) 2
Dissertation (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (202) 202
oncology (180) 180
female (162) 162
middle aged (125) 125
index medicus (119) 119
adult (114) 114
aged (99) 99
breast cancer (86) 86
cancer (82) 82
antineoplastic combined chemotherapy protocols - therapeutic use (76) 76
chemotherapy (76) 76
breast neoplasms - drug therapy (74) 74
male (59) 59
article (56) 56
breast neoplasms - pathology (53) 53
treatment outcome (51) 51
care and treatment (37) 37
disease-free survival (36) 36
prognosis (35) 35
therapy (35) 35
doxorubicin - administration & dosage (33) 33
aged, 80 and over (32) 32
breast neoplasms - genetics (31) 31
neoplasm staging (31) 31
clinical trials (30) 30
paclitaxel (30) 30
survival (28) 28
antineoplastic combined chemotherapy protocols - adverse effects (27) 27
medicine & public health (27) 27
drug administration schedule (26) 26
beer (25) 25
biochemistry (25) 25
chemistry (25) 25
compositions or test papers therefor (25) 25
condition-responsive control in microbiological orenzymological processes (25) 25
cyclophosphamide - administration & dosage (25) 25
enzymology (25) 25
measuring or testing processes involving enzymes, nucleicacids or microorganisms (25) 25
metallurgy (25) 25
microbiology (25) 25
mutation or genetic engineering (25) 25
processes of preparing such compositions (25) 25
spirits (25) 25
survival analysis (25) 25
vinegar (25) 25
wine (25) 25
antineoplastic agents - therapeutic use (24) 24
women (24) 24
research (23) 23
breast neoplasms - mortality (22) 22
metastasis (21) 21
neoplasm metastasis (21) 21
breast neoplasms - metabolism (20) 20
chemotherapy, adjuvant (20) 20
recurrence (20) 20
trastuzumab (20) 20
tamoxifen (19) 19
combination (18) 18
gene expression (18) 18
health aspects (18) 18
investigating or analysing materials by determining theirchemical or physical properties (18) 18
lymphoma, aids-related - drug therapy (18) 18
measuring (18) 18
physics (18) 18
risk factors (18) 18
testing (18) 18
antineoplastic combined chemotherapy protocols - administration & dosage (17) 17
expression (17) 17
infusions, intravenous (17) 17
lymphoma, non-hodgkin - drug therapy (17) 17
paclitaxel - administration & dosage (17) 17
active antiretroviral therapy (16) 16
carcinoma (16) 16
clinical trials as topic (16) 16
drug therapy (16) 16
hematology (16) 16
survival rate (16) 16
toxicity (16) 16
abridged index medicus (15) 15
aids (15) 15
anthracyclines (15) 15
cyclophosphamide (15) 15
kaplan-meier estimate (15) 15
medicine, general & internal (15) 15
b-cell lymphoma (14) 14
breast neoplasms - surgery (14) 14
receptors, estrogen - metabolism (14) 14
rituximab (14) 14
taxoids - administration & dosage (14) 14
adenocarcinoma - drug therapy (13) 13
analysis (13) 13
antineoplastic agents - administration & dosage (13) 13
cancer therapies (13) 13
docetaxel (13) 13
dose-response relationship, drug (13) 13
doxorubicin (13) 13
doxorubicin - adverse effects (13) 13
etoposide - administration & dosage (13) 13
neoadjuvant therapy (13) 13
oncology, experimental (13) 13
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMC UROLOGY, ISSN 1471-2490, 09/2019, Volume 19, Issue 1, pp. 1 - 11
Background Despite international recommendations of including patient-reported outcomes (PROs) in randomised clinical trials (RCTs), a 2014 review concluded... 
CALMETTE-GUERIN INSTILLATION | Outcome measurement | RCT | PROs | EFFICACY | METAANALYSES | TUMOR | DISCOMFORT | Bladder cancer | Quality of life | IMPACT | THERAPY | RADICAL CYSTECTOMY | UROLOGY & NEPHROLOGY | QUALITY-OF-LIFE | TRANSURETHRAL RESECTION | Studies | Medical research | Demography | Immunotherapy | Clinical trials | Oncology | Systematic review | Blood diseases | Patients | Cancer
Journal Article
npj Breast Cancer, ISSN 2374-4677, 12/2019, Volume 5, Issue 1, pp. 1 - 9
Antibodies blocking programmed death 1 (anti-PD-1) or its ligand (anti-PD-L1) are associated with modest response rates as monotherapy in metastatic breast... 
Medical research | Immunoglobulins | Research funding | Research & development--R&D | Cytotoxicity | Oncology | Breast cancer | Metastasis | Radiation therapy | Cancer therapies | Medicine | Chemotherapy | Immunotherapy | Surgery | Biomarkers | Ligands
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2019, Volume 381, Issue 13, pp. 1289 - 1291
To the Editor: Sparano et al. (June 20 issue) 1 report prognostic and predictive implications by integrating clinical-risk stratification with a 21-gene assay... 
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 09/2019, Volume 37, Issue 25, pp. 2206 - 2206
PURPOSE The KRISTINE study compared neoadjuvant trastuzumab emtansine plus pertuzumab (T-DM1+P) with docetaxel, carboplatin, trastuzumab plus P (TCH+P) for the... 
TRIAL | LAPATINIB | SURVIVAL | MULTICENTER | EFFICACY | ONCOLOGY | NEOSPHERE | OPEN-LABEL | CHEMOTHERAPY PLUS TRASTUZUMAB | TH3RESA | PHYSICIANS CHOICE
Journal Article
JNCI Cancer Spectrum, ISSN 2515-5091, 08/2019
Abstract Purpose The Trial Assigning Individualized Options for Treatment (TAILORx) found chemotherapy could be omitted in many women with hormone receptor... 
Journal Article
JAMA Oncology, ISSN 2374-2437, 2019, Volume 5, Issue 8, pp. 1205 - 1214
ImportanceThere is tremendous interest in using immunotherapy to treat breast cancer, as evidenced by the more than 290 clinical trials ongoing at the time of... 
TUMOR-INFILTRATING LYMPHOCYTES | CTLA-4 BLOCKADE | TRASTUZUMAB | ONCOLOGY | LOCAL RADIATION | PREDICTIVE-VALUE | ANTITUMOR IMMUNITY | RADIOTHERAPY | PROGNOSTIC VALUE | RADIATION-THERAPY | METASTATIC BREAST
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 07/2019, Volume 37, Issue 21, pp. 1841 - 1841
Journal Article
JAMA Oncology, ISSN 2374-2437, 2019, Volume 5, Issue 7, pp. 1036 - 1042
IMPORTANCE Advanced diagnostics, such as magnetic resonance imaging (MRI) and gene expression profiles, are potentially useful to guide targeted treatment in... 
MANAGEMENT | LOCAL RECURRENCE | ONCOLOGY | MRI | RISK | CANCER | TRENDS
Journal Article
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 06/2019, p. JCO1900828
Journal Article
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 06/2019, p. JCO1900882
The KRISTINE study compared neoadjuvant trastuzumab emtansine plus pertuzumab (T-DM1+P) with docetaxel, carboplatin, trastuzumab plus P (TCH+P) for the... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. 526 - 526
Journal Article
by Gray, Richard and Bradley, Rosie and Braybrooke, Jeremy and Liu, Zulian and Liu, Hui and Peto, Richard and Davies, Lucy and Davies, Christina and Dodwell, David and McGale, Paul and Pan, Hongchao and Taylor, Carolyn and Barlow, William and Bliss, Judith and Bruzzi, Paolo and Cameron, David and Fountzilas, George and Loibl, Sibylle and Mackey, John and Martin, Miguel and Del Mastro, Lucia and Möbus, Volker and Nekljudova, Valentina and De Placido, Sabino and Swain, Sandra and Untch, Michael and Pritchard, Kathleen I and Bergh, Jonas and Norton, Larry and Boddington, Clare and Burrett, Julie and Clarke, Mike and Duane, Fran and Evans, Vaughan and Gettins, Lucy and Godwin, Jon and Hills, Robert and James, Sam and MacKinnon, Elizabeth and Mannu, Gurdeep and McHugh, Theresa and Morris, Philip and Read, Simon and Wang, Xiang and Wang, Zhe and Wang, Yaochen and Fasching, Peter and Harbeck, Nadia and Piedbois, Pascal and Gnant, Michael and Steger, Guenther and Di Leo, Angelo and Dolci, Stella and Francis, Prue and Larsimont, Denis and Nogaret, Jean Marie and Philippson, Catherine and Piccart, Martine and Linn, Sabine and Peer, Petronella and Tjan-Heijnen, Vivianne and Vliek, Sonja and Slamon, Dennis and Bartlett, John and Bramwell, Vivien H and Chen, Bingshu and Chia, Stephen and Gelmon, Karen and Goss, Paul and Levine, Mark and Parulekar, Wendy and Pater, Joseph and Rakovitch, Eileen and Shepherd, Lois and Tu, Dongsheng and Whelan, Tim and Berry, Don and Broadwater, Gloria and Cirrincione, Constance and Muss, Hyman and Weiss, Raymond and Shan, Yi and Shao, Yong Fu and Xu, Binghe and Zhao, Dong-Bing and Bartelink, Harry and Bijker, Nina and Bogaerts, Jan and Cardoso, Fatima and Cufer, Tanja and Julien, Jean-Pierre and Poortmans, Philip and Rutgers, Emiel and van de Velde, Cornelis and Carrasco, Eva and Segui, Miguel Angel and Blohmer, Jens Uwe and Costa, Serban and Gerber, Bernd and Jackisch, Christian and ... and Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
The Lancet, ISSN 0140-6736, 04/2019, Volume 393, Issue 10179, pp. 1440 - 1452
Journal Article
JAMA ONCOLOGY, ISSN 2374-2437, 04/2019, Volume 5, Issue 4, pp. 574 - 574
Journal Article